Market LIVE
Published markets; coverage varies by country
Product profile · United States

OPFOLDA

 ·  Patent Litigation & Settlement History ↓

IngredientMIGLUSTAT
Application typeNDA
Application215211
Product001
Dosage formCAPSULE
RouteORAL
Strength65MG
Approval date2023-09-28
Marketing statusPrescription
Status event—
ApplicantAMICUS THERAP US
Product source

Current GenericRadar decision

Year2037
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2037-08-12
Patent anchor2037-08-12
Exclusivity anchor2026-09-28
Protection date2038-09-16
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2037. Anchor type: DS_EQUIVALENT_PATENT. Patent anchor: 2037-08-12. Exclusivity anchor: 2026-09-28. Anchor date: 2037-08-12. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
105126772033-03-07U U-3726NNU
English description not available.
———
105126772033-03-07ORANGE_BOOK U-3726NNU
English description not available.
———
112785992033-03-07U U-3726NNU
English description not available.
———
112785992033-03-07ORANGE_BOOK U-3726NNU
English description not available.
———
124199372033-03-07U U-3726NNU
English description not available.
———
124199372033-03-07ORANGE_BOOK U-3726NNU
English description not available.
———
102082992035-09-30DS/DP/U U-3726NNOTHER
English description not available.
———
102082992035-09-30ORANGE_BOOK U-3726NNOTHER
English description not available.
———
109615222035-09-30U U-3726NNU
English description not available.
———
109615222035-09-30ORANGE_BOOK U-3726NNU
English description not available.
———
117536322035-09-30U U-3726NNU
English description not available.
———
117536322035-09-30ORANGE_BOOK U-3726NNU
English description not available.
———
112786012036-12-29DP/U U-3726NNU
English description not available.
———
112786012036-12-29ORANGE_BOOK U-3726NNU
English description not available.
———
124149852036-12-29U U-3726NNU
English description not available.
———
124149852036-12-29ORANGE_BOOK U-3726NNU
English description not available.
———
108572122037-08-12U U-3726NNU
English description not available.
———
108572122037-08-12ORANGE_BOOK U-3726NNU
English description not available.
———
122460622038-09-16U U-3726NNU
English description not available.
———
122460622038-09-16ORANGE_BOOK U-3726NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2023-09-282026-09-28English description not available.YY2026-09-28—Source
NP2023-09-282026-09-28English description not available.YY2026-09-28
NP
Full coverage date: 2026-09-28
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (12)
TypeDateRoleBasisSource
PATENT2033-03-07FTO_TAILEnglish description not available.Source
PATENT2033-03-07FTO_TAILEnglish description not available.Source
PATENT2033-03-07FTO_TAILEnglish description not available.Source
PATENT2035-09-30FTO_TAILEnglish description not available.Source
PATENT2035-09-30FTO_TAILEnglish description not available.Source
PATENT2035-09-30FTO_TAILEnglish description not available.Source
PATENT2036-12-29FTO_TAILEnglish description not available.Source
PATENT2036-12-29FTO_TAILEnglish description not available.Source
PATENT2037-08-12FTO_TAILEnglish description not available.Source
PATENT2038-09-16FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_STATUS2026-09-28CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.